期刊文献+

胺碘酮在急性心肌梗死院前急救中预防性应用的研究 被引量:10

Study on Prophylactic Application of Amiodarone in Treatment of Acute Myocardial Infarction in Pre-hospital Care
下载PDF
导出
摘要 目的:探讨在急性心肌梗死(AMI)院前急救中预防性应用胺碘酮对恶性心律失常的发生、除颤使用率的影响及安全性。方法:采用前瞻性随机对照原则,将院前急救过程中诊断ST段抬高型AMI的患者94例,分为预防性应用胺碘酮实施组和常规治疗组,统计恶性心律失常、除颤、死亡、不良反应例数。结果:实施组43例,对照组51例。恶性心律失常发生率分别为21%和90%(P<0.01);除颤使用率分别为9.3%和23.5%(P<0.01);死亡率分别为2.3%和5.9%(P<0.05);实施组不良反应9例。结论:在AMI院前急救中,预防性应用胺碘酮可显著降低恶性心律失常发生率,减少除颤的使用率,增加抢救成功率,无严重不良反应。 Objective: To explore the effect of prophylactic application of amiodarone on malignant arrhythmia in pre-hospital care for treatment of acute myocardial infarction (AMI) and its safety. Methods: Ninety-four patients diagnosed as ST elevated AMI in pre-hospital care were divided into two groups: Amiodarone prophylactic appIication group and routine treatment group. Cases of malignant arrhythmia, reversion of fibrillation, death and adverse reaction were statistically analyzed. Results: The rate of malignant arrhythmia were 21% in amiodarone prophylactic application group and 90% in routine treatment group (P〈0. 01). The rate of reversion of fibrillation were 9. 3% in amiodarone prophylactic application group and 23. 5% in routine treatment group (P〈0. 01). The death rate were 2. 3% in amiodarone prophylactic application group and 5, 9% in routine treatment group (P〈0. 05). Adverse reactions were observed in 9 cases in amiodarone prophylactic application group. Conclusions: Prophylactic application of amiodarone can signifieantly decrease the incidence of malignant arrhythmia, decrease the utilization rate of defibrillator, increase the rate of successful rescue, and with no severe adverse reaction.
出处 《内科急危重症杂志》 2009年第3期148-149,163,共3页 Journal of Critical Care In Internal Medicine
关键词 胺碘酮 急性心肌梗死 院前急救 Amiodarone Acute myocardial infarction Pre-hospital care
  • 相关文献

参考文献10

  • 1中华心血管病杂志编委会.急性心肌梗死溶栓治疗参考方案[J].中华心血管病杂志,1991,19(3):137-139.
  • 2吴文溪.临床重症治疗与监护.南京:江苏科学技术出版社,1997,208.
  • 3郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 4Nacearelli GV, Dougherty AH. Amiodarone SW. A review of its pharmacologic antiarrhythrnie and adverse effects. In: Podrid P J, Kowey P R, eds. Cardiac arrhythmia: Mechanisms , diagnosis, and management. Baltimore: Williams & Wilkins, 1995. 434.
  • 5郭乐凌,王志凯,聂凌.用QT间期离散度监测充血性心力衰竭患者使用抗心律失常药物致心律失常的研究[J].中国危重病急救医学,1999,11(7):427-427. 被引量:11
  • 6Burkart F, Pfisterer M, Kiowski W, et at. Effect of antiarrhyth- mic therapy on mortality on survivors of myocardial infarction with symptomatic complex ventrieular arrhythmias: basel arrhythmic: basel arrhythmie stady of infact swrvial. J Am coll cardiol, 1990. 16:1711.
  • 7Cairns JA, Connolly SJ, Roberts RS, et al. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Invesgators. Randomized trial of outcome ofter myocardial infarction in patients with frequent or repetitive ventricular premature depolarization: CAMIT. Lancet, 1999,353:9.
  • 8Amiodarone Trials Meta-Analysis Invesgators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: metaanalysis of individual data from 6500 patients in randomised trials. Lancet, 1997, 350: 1417.
  • 9Kndenchuk PJ, Cabb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl reed, 1999,341:871.
  • 10谭显武,谢素红,覃立行.心搏骤停时心肺复苏30例相关因素分析[J].中国危重病急救医学,2006,18(4):209-209. 被引量:8

二级参考文献12

  • 1Cui G,Circulation,1992年,86卷,增1期,393页
  • 2Guidelines 2000 for CPR and ECG[J].Resuscitation,2000,46:1-3.
  • 3Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 4Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 5Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
  • 6The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
  • 7Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
  • 8Khan IA.Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J ,2004,25:1 274
  • 9Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
  • 10谢瑞芹,王凤飞,周保军,都军,郝玉明,刘凡,李拥军,杨晓红.盐酸苯那普利对冠心病心力衰竭患者校正后QT间期离散度的影响[J].中国循环杂志,1998,13(5):277-279. 被引量:14

共引文献419

同被引文献59

引证文献10

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部